ImmunityBio, Inc. - Common Stock (NQ:IBRX)
All News about ImmunityBio, Inc. - Common Stock





















ImmunityBio Awarded Seminal Patent on Natural Killer Cells
January 04, 2022
From ImmunityBio, Inc.
Via Business Wire






Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.